Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: From protein buffer capacity prediction to bioprocess applications-Reference-Cited by-同舟云学术

Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: From protein buffer capacity prediction to bioprocess applications

Published:2015-04 Issue:4 Volume:10 Page:610-622
ISSN:1860-6768
Container-title:Biotechnology Journal
language:en
Short-container-title:Biotechnology Journal

Author:

Bahrenburg Sven,Karow Anne R.,Garidel Patrick

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/biot.201400531/fullpdf

Reference33 articles.

1. Collected studies on immunity

2. Monoclonal antibodies: Versatile platforms for cancer immunotherapy.;Weiner;Nat. Rev. Immunol.,2010

3. Buffer capacity of biologics - from buffer salts to buffering by antibodies.;Karow;Biotechnol. Prog.,2013

4. Self-buffering antibody formulations.;Gokarn;J. Pharm. Sci.,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(glutamic acid)-Based Viscosity Reducers for Concentrated Formulations of a Monoclonal IgG Antibody;Molecular Pharmaceutics;2024-01-19

2. Use of Synchrotron Radiation Circular Dichroism to Analyze the Interaction and Insertion of Proteins into Bacterial Outer Membrane Vesicles;Methods in Molecular Biology;2024

3. Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations;Journal of Chemical Information and Modeling;2023-09-27

4. Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations;2023-08-29

5. A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations;mAbs;2023-05-27